[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Meningococcal Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

January 2020 | 105 pages | ID: G5D934481CCEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

MARKET OVERVIEW

The global Meningococcal Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.2% in the forecast period of 2020 to 2025 and will expected to reach USD 290.5 million by 2025, from USD 245.9 million in 2019.
The Meningococcal Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

MARKET SEGMENTATION

Meningococcal Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Meningococcal Vaccine market has been segmented into Quadrivalent, Bivalent, Others, etc.
By Application, Meningococcal Vaccine has been segmented into Pneumonia, Meningitis, Bacteremia, Others (Arthritis, Conjunctivitis, Urethritis), etc.

REGIONS AND COUNTRIES LEVEL ANALYSIS

Regional analysis is another highly comprehensive part of the research and analysis study of the global Meningococcal Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Meningococcal Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Meningococcal Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Meningococcal Vaccine market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Meningococcal Vaccine markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.

Competitive Landscape and Meningococcal Vaccine Market Share Analysis
Meningococcal Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Meningococcal Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Meningococcal Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Meningococcal Vaccine are: Novartis, Bio-Med, CSL, GSK, Serum Institute of India, Merck, Hualan Bio, JN International Medical Corporation, Baxter, China National Biotec Group, Walvax, Zhifei, etc. Among other players domestic and global, Meningococcal Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Meningococcal Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Meningococcal Vaccine, with price, sales, revenue and global market share of Meningococcal Vaccine in 2018 and 2019.
Chapter 3, the Meningococcal Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meningococcal Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Meningococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Meningococcal Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW

1.1 Meningococcal Vaccine Introduction
1.2 Market Analysis by Type
  1.2.1 Overview: Global Meningococcal Vaccine Revenue by Type: 2015 VS 2019 VS 2025
  1.2.2 Quadrivalent
  1.2.3 Bivalent
  1.2.4 Others
1.3 Market Analysis by Application
  1.3.1 Overview: Global Meningococcal Vaccine Revenue by Application: 2015 VS 2019 VS 2025
  1.3.2 Pneumonia
  1.3.3 Meningitis
  1.3.4 Bacteremia
  1.3.5 Others (Arthritis, Conjunctivitis, Urethritis)
1.4 Overview of Global Meningococcal Vaccine Market
  1.4.1 Global Meningococcal Vaccine Market Status and Outlook (2015-2025)
  1.4.2 North America (United States, Canada and Mexico)
  1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
  1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Novartis
  2.1.1 Novartis Details
  2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
  2.1.3 Novartis SWOT Analysis
  2.1.4 Novartis Product and Services
  2.1.5 Novartis Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bio-Med
  2.2.1 Bio-Med Details
  2.2.2 Bio-Med Major Business and Total Revenue (Financial Highlights) Analysis
  2.2.3 Bio-Med SWOT Analysis
  2.2.4 Bio-Med Product and Services
  2.2.5 Bio-Med Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 CSL
  2.3.1 CSL Details
  2.3.2 CSL Major Business and Total Revenue (Financial Highlights) Analysis
  2.3.3 CSL SWOT Analysis
  2.3.4 CSL Product and Services
  2.3.5 CSL Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GSK
  2.4.1 GSK Details
  2.4.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
  2.4.3 GSK SWOT Analysis
  2.4.4 GSK Product and Services
  2.4.5 GSK Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Serum Institute of India
  2.5.1 Serum Institute of India Details
  2.5.2 Serum Institute of India Major Business and Total Revenue (Financial Highlights) Analysis
  2.5.3 Serum Institute of India SWOT Analysis
  2.5.4 Serum Institute of India Product and Services
  2.5.5 Serum Institute of India Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
  2.6.1 Merck Details
  2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
  2.6.3 Merck SWOT Analysis
  2.6.4 Merck Product and Services
  2.6.5 Merck Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Hualan Bio
  2.7.1 Hualan Bio Details
  2.7.2 Hualan Bio Major Business and Total Revenue (Financial Highlights) Analysis
  2.7.3 Hualan Bio SWOT Analysis
  2.7.4 Hualan Bio Product and Services
  2.7.5 Hualan Bio Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 JN International Medical Corporation
  2.8.1 JN International Medical Corporation Details
  2.8.2 JN International Medical Corporation Major Business and Total Revenue (Financial Highlights) Analysis
  2.8.3 JN International Medical Corporation SWOT Analysis
  2.8.4 JN International Medical Corporation Product and Services
  2.8.5 JN International Medical Corporation Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Baxter
  2.9.1 Baxter Details
  2.9.2 Baxter Major Business and Total Revenue (Financial Highlights) Analysis
  2.9.3 Baxter SWOT Analysis
  2.9.4 Baxter Product and Services
  2.9.5 Baxter Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 China National Biotec Group
  2.10.1 China National Biotec Group Details
  2.10.2 China National Biotec Group Major Business and Total Revenue (Financial Highlights) Analysis
  2.10.3 China National Biotec Group SWOT Analysis
  2.10.4 China National Biotec Group Product and Services
  2.10.5 China National Biotec Group Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Walvax
  2.11.1 Walvax Details
  2.11.2 Walvax Major Business and Total Revenue (Financial Highlights) Analysis
  2.11.3 Walvax SWOT Analysis
  2.11.4 Walvax Product and Services
  2.11.5 Walvax Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Zhifei
  2.12.1 Zhifei Details
  2.12.2 Zhifei Major Business and Total Revenue (Financial Highlights) Analysis
  2.12.3 Zhifei SWOT Analysis
  2.12.4 Zhifei Product and Services
  2.12.5 Zhifei Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 SALES, REVENUE AND MARKET SHARE BY MANUFACTURER

3.1 Global Meningococcal Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Meningococcal Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
  3.3.1 Top 3 Meningococcal Vaccine Manufacturer Market Share in 2019
  3.3.2 Top 6 Meningococcal Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend

4 GLOBAL MARKET ANALYSIS BY REGIONS

4.1 Global Meningococcal Vaccine Sales, Revenue and Market Share by Regions
  4.1.1 Global Meningococcal Vaccine Sales and Market Share by Regions (2015-2020)
  4.1.2 Global Meningococcal Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Meningococcal Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Meningococcal Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Meningococcal Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Meningococcal Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Meningococcal Vaccine Sales and Growth Rate (2015-2020)

5 NORTH AMERICA BY COUNTRY

5.1 North America Meningococcal Vaccine Sales, Revenue and Market Share by Country
  5.1.1 North America Meningococcal Vaccine Sales and Market Share by Country (2015-2020)
  5.1.2 North America Meningococcal Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Meningococcal Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Meningococcal Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Meningococcal Vaccine Sales and Growth Rate (2015-2020)

6 EUROPE BY COUNTRY

6.1 Europe Meningococcal Vaccine Sales, Revenue and Market Share by Country
  6.1.1 Europe Meningococcal Vaccine Sales and Market Share by Country (2015-2020)
  6.1.2 Europe Meningococcal Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Meningococcal Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Meningococcal Vaccine Sales and Growth Rate (2015-2020)
6.4 France Meningococcal Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Meningococcal Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Meningococcal Vaccine Sales and Growth Rate (2015-2020)

7 ASIA-PACIFIC BY REGIONS

7.1 Asia-Pacific Meningococcal Vaccine Sales, Revenue and Market Share by Regions
  7.1.1 Asia-Pacific Meningococcal Vaccine Sales and Market Share by Regions (2015-2020)
  7.1.2 Asia-Pacific Meningococcal Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Meningococcal Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Meningococcal Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Meningococcal Vaccine Sales and Growth Rate (2015-2020)
7.5 India Meningococcal Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Meningococcal Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Meningococcal Vaccine Sales and Growth Rate (2015-2020)

8 SOUTH AMERICA BY COUNTRY

8.1 South America Meningococcal Vaccine Sales, Revenue and Market Share by Country
  8.1.1 South America Meningococcal Vaccine Sales and Market Share by Country (2015-2020)
  8.1.2 South America Meningococcal Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Meningococcal Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Meningococcal Vaccine Sales and Growth Rate (2015-2020)

9 MIDDLE EAST & AFRICA BY COUNTRIES

9.1 Middle East & Africa Meningococcal Vaccine Sales, Revenue and Market Share by Country
  9.1.1 Middle East & Africa Meningococcal Vaccine Sales and Market Share by Country (2015-2020)
  9.1.2 Middle East & Africa Meningococcal Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Meningococcal Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Meningococcal Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Meningococcal Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Meningococcal Vaccine Sales and Growth Rate (2015-2020)

10 MARKET SEGMENT BY TYPE

10.1 Global Meningococcal Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Meningococcal Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Meningococcal Vaccine Price by Type (2015-2020)

11 GLOBAL MENINGOCOCCAL VACCINE MARKET SEGMENT BY APPLICATION

11.1 Global Meningococcal Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Meningococcal Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Meningococcal Vaccine Price by Application (2015-2020)

12 MARKET FORECAST

12.1 Global Meningococcal Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Meningococcal Vaccine Market Forecast by Regions (2021-2025)
  12.2.1 North America Meningococcal Vaccine Market Forecast (2021-2025)
  12.2.2 Europe Meningococcal Vaccine Market Forecast (2021-2025)
  12.2.3 Asia-Pacific Meningococcal Vaccine Market Forecast (2021-2025)
  12.2.4 South America Meningococcal Vaccine Market Forecast (2021-2025)
  12.2.5 Middle East & Africa Meningococcal Vaccine Market Forecast (2021-2025)
12.3 Meningococcal Vaccine Market Forecast by Type (2021-2025)
  12.3.1 Global Meningococcal Vaccine Sales Forecast by Type (2021-2025)
  12.3.2 Global Meningococcal Vaccine Market Share Forecast by Type (2021-2025)
12.4 Meningococcal Vaccine Market Forecast by Application (2021-2025)
  12.4.1 Global Meningococcal Vaccine Sales Forecast by Application (2021-2025)
  12.4.2 Global Meningococcal Vaccine Market Share Forecast by Application (2021-2025)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

LIST OF TABLES

Table 1. Global Meningococcal Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Meningococcal Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Meningococcal Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Meningococcal Vaccine Major Business
Table 9. Novartis Meningococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. Novartis SWOT Analysis
Table 11. Novartis Meningococcal Vaccine Product and Services
Table 12. Novartis Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 14. Bio-Med Meningococcal Vaccine Major Business
Table 15. Bio-Med Meningococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Bio-Med SWOT Analysis
Table 17. Bio-Med Meningococcal Vaccine Product and Services
Table 18. Bio-Med Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. CSL Basic Information, Manufacturing Base and Competitors
Table 20. CSL Meningococcal Vaccine Major Business
Table 21. CSL Meningococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. CSL SWOT Analysis
Table 23. CSL Meningococcal Vaccine Product and Services
Table 24. CSL Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. GSK Basic Information, Manufacturing Base and Competitors
Table 26. GSK Meningococcal Vaccine Major Business
Table 27. GSK Meningococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. GSK SWOT Analysis
Table 29. GSK Meningococcal Vaccine Product and Services
Table 30. GSK Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 32. Serum Institute of India Meningococcal Vaccine Major Business
Table 33. Serum Institute of India Meningococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 34. Serum Institute of India SWOT Analysis
Table 35. Serum Institute of India Meningococcal Vaccine Product and Services
Table 36. Serum Institute of India Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merck Basic Information, Manufacturing Base and Competitors
Table 38. Merck Meningococcal Vaccine Major Business
Table 39. Merck Meningococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 40. Merck SWOT Analysis
Table 41. Merck Meningococcal Vaccine Product and Services
Table 42. Merck Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 44. Hualan Bio Meningococcal Vaccine Major Business
Table 45. Hualan Bio Meningococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 46. Hualan Bio SWOT Analysis
Table 47. Hualan Bio Meningococcal Vaccine Product and Services
Table 48. Hualan Bio Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. JN International Medical Corporation Basic Information, Manufacturing Base and Competitors
Table 50. JN International Medical Corporation Meningococcal Vaccine Major Business
Table 51. JN International Medical Corporation Meningococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 52. JN International Medical Corporation SWOT Analysis
Table 53. JN International Medical Corporation Meningococcal Vaccine Product and Services
Table 54. JN International Medical Corporation Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Baxter Basic Information, Manufacturing Base and Competitors
Table 56. Baxter Meningococcal Vaccine Major Business
Table 57. Baxter Meningococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 58. Baxter SWOT Analysis
Table 59. Baxter Meningococcal Vaccine Product and Services
Table 60. Baxter Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. China National Biotec Group Basic Information, Manufacturing Base and Competitors
Table 62. China National Biotec Group Meningococcal Vaccine Major Business
Table 63. China National Biotec Group Meningococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 64. China National Biotec Group SWOT Analysis
Table 65. China National Biotec Group Meningococcal Vaccine Product and Services
Table 66. China National Biotec Group Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Walvax Basic Information, Manufacturing Base and Competitors
Table 68. Walvax Meningococcal Vaccine Major Business
Table 69. Walvax Meningococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 70. Walvax SWOT Analysis
Table 71. Walvax Meningococcal Vaccine Product and Services
Table 72. Walvax Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Zhifei Basic Information, Manufacturing Base and Competitors
Table 74. Zhifei Meningococcal Vaccine Major Business
Table 75. Zhifei Meningococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 76. Zhifei SWOT Analysis
Table 77. Zhifei Meningococcal Vaccine Product and Services
Table 78. Zhifei Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Meningococcal Vaccine Sales by Manufacturer (2018-2019) (K Dose)
Table 80. Global Meningococcal Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Meningococcal Vaccine Sales by Regions (2015-2020) (K Dose)
Table 82. Global Meningococcal Vaccine Sales Market Share by Regions (2015-2020)
Table 83. Global Meningococcal Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Meningococcal Vaccine Sales by Countries (2015-2020) (K Dose)
Table 85. North America Meningococcal Vaccine Sales Market Share by Countries (2015-2020)
Table 86. North America Meningococcal Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Meningococcal Vaccine Revenue Market Share by Countries (2015-2020)
Table 88. Europe Meningococcal Vaccine Sales by Countries (2015-2020) (K Dose)
Table 89. Europe Meningococcal Vaccine Sales Market Share by Countries (2015-2020)
Table 90. Europe Meningococcal Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Meningococcal Vaccine Sales by Regions (2015-2020) (K Dose)
Table 92. Asia-Pacific Meningococcal Vaccine Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Meningococcal Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Meningococcal Vaccine Sales by Countries (2015-2020) (K Dose)
Table 95. South America Meningococcal Vaccine Sales Market Share by Countries (2015-2020)
Table 96. South America Meningococcal Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Meningococcal Vaccine Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Meningococcal Vaccine Sales by Countries (2015-2020) (K Dose)
Table 99. Middle East & Africa Meningococcal Vaccine Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Meningococcal Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Meningococcal Vaccine Revenue Market Share by Countries (2015-2020)
Table 102. Global Meningococcal Vaccine Sales by Type (2015-2020) (K Dose)
Table 103. Global Meningococcal Vaccine Sales Share by Type (2015-2020)
Table 104. Global Meningococcal Vaccine Revenue by Type (2015-2020) (USD Million)
Table 105. Global Meningococcal Vaccine Revenue Share by Type (2015-2020)
Table 106. Global Meningococcal Vaccine Sales by Application (2015-2020) (K Dose)
Table 107. Global Meningococcal Vaccine Sales Share by Application (2015-2020)
Table 108. Global Meningococcal Vaccine Sales Forecast by Regions (2021-2025) (K Dose)
Table 109. Global Meningococcal Vaccine Market Share Forecast by Regions (2021-2025)
Table 110. Global Meningococcal Vaccine Sales Forecast by Type (2021-2025) (K Dose)
Table 111. Global Meningococcal Vaccine Market Share Forecast by Type (2021-2025)
Table 112. Global Meningococcal Vaccine Sales Forecast by Application (2021-2025)
Table 113. Global Meningococcal Vaccine Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List

LIST OF FIGURES

Figure 1. Meningococcal Vaccine Picture
Figure 2. Global Sales Market Share of Meningococcal Vaccine by Type in 2019
Figure 3. Quadrivalent Picture
Figure 4. Bivalent Picture
Figure 5. Others Picture
Figure 6. Meningococcal Vaccine Sales Market Share by Application in 2018
Figure 7. Pneumonia Picture
Figure 8. Meningitis Picture
Figure 9. Bacteremia Picture
Figure 10. Others (Arthritis, Conjunctivitis, Urethritis) Picture
Figure 11. Global Meningococcal Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Meningococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Meningococcal Vaccine Sales Market Share by Manufacturer in 2019
Figure 32. Global Meningococcal Vaccine Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Meningococcal Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Meningococcal Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 37. Global Meningococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Meningococcal Vaccine Revenue Market Share by Regions (2015-2020)
Figure 39. Global Meningococcal Vaccine Revenue Market Share by Regions in 2018
Figure 40. North America Meningococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Europe Meningococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Meningococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 43. South America Meningococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Meningococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 45. North America Meningococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Meningococcal Vaccine Sales Market Share by Countries (2015-2020)
Figure 47. North America Meningococcal Vaccine Sales Market Share by Countries in 2018
Figure 48. North America Meningococcal Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Meningococcal Vaccine Revenue Market Share by Countries in 2018
Figure 50. United States Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 51. Canada Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 52. Mexico Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 53. Europe Meningococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Meningococcal Vaccine Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Meningococcal Vaccine Revenue Market Share by Countries in 2019
Figure 56. Germany Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 57. UK Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 58. France Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 59. Russia Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 60. Italy Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 61. Asia-Pacific Meningococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Meningococcal Vaccine Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Meningococcal Vaccine Revenue Market Share by Regions 2019
Figure 64. China Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 65. Japan Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 66. Korea Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 67. India Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 68. Southeast Asia Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 69. South America Meningococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Meningococcal Vaccine Sales Market Share by Countries in 2019
Figure 71. South America Meningococcal Vaccine Revenue Market Share by Countries in 2019
Figure 72. Brazil Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 73. Argentina Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 74. Middle East and Africa Meningococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Meningococcal Vaccine Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Meningococcal Vaccine Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Meningococcal Vaccine Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 79. Egypt Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 80. Turkey Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 81. South Africa Meningococcal Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 82. Global Meningococcal Vaccine Sales and Growth Rate (2021-2025) (K Dose)
Figure 83. Global Meningococcal Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Meningococcal Vaccine Market Forecast (2021-2025) (K Dose)
Figure 85. Europe Sales Meningococcal Vaccine Market Forecast (2021-2025) (K Dose)
Figure 86. Asia-Pacific Sales Meningococcal Vaccine Market Forecast (2021-2025) (K Dose)
Figure 87. South America Sales Meningococcal Vaccine Market Forecast (2021-2025) (K Dose)
Figure 88. Middle East & Africa Sales Meningococcal Vaccine Market Forecast (2021-2025) (K Dose)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel


More Publications